You just read:

Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories

News provided by

Theravance Biopharma, Inc.

Jun 14, 2019, 08:05 ET